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Abstract
Background: Both host and pathogen factors contribute to disease outcome in Plasmodium
falciparum infection. The feasibility of studying the P. falciparum in vivo transcriptome to understand
parasite transcriptional response while it resides in the human host is presented.
Methods: A custom made oligonucleotide array with probes based on the P. falciparum 3D7
laboratory strain chromosome 2 sequence was used to detect in vivo P. falciparum transcripts. This
study analyzed transcripts from total RNA derived from small blood samples of P. falciparum
infected patients and compared the in vivo expression profile to the in vitro cultivated 3D7 strain
transcriptome.
Results: The data demonstrated that in vivo transcription can be studied from a small blood sample,
despite the abundance of human RNA. The in vivo transcriptome is similar to the 3D7 ring stage
transcriptome, but there are significant differences in genes encoding a sexual stage antigen and
surface proteins.
Conclusions: Whole genome transcription analysis of P. falciparum can be carried out successfully
and further studies in selected patient cohorts may provide insight into parasite in vivo biology and
defense against host immunity.
Background
Plasmodium falciparum infection remains a major health
problem worldwide. Its complex life cycle has hampered
standard methods for the study of pathogenesis. New
approaches to elucidate parasite biology using whole
genomic methods have provided insight into gene func-
tion, transcriptional regulation and stage specific biology
[1-4]. Characterization of the in vivo biology of this path-
ogen, through adaptation of a whole genome approach,
would provide insight into the host-parasite relationship,
parasite virulence factors and inform new strategies for
intervention. Genomic scale transcriptional profiling of P.
Published: 05 August 2004
Malaria Journal 2004, 3:30 doi:10.1186/1475-2875-3-30
Received: 01 June 2004
Accepted: 05 August 2004
This article is available from: http://www.malariajournal.com/content/3/1/30
© 2004 Daily et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Malaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
Page 2 of 8
(page number not for citation purposes)
falciparum during a natural infection is presented. Small
amounts of parasite RNA, isolated from a few milliliters of
a blood sample are found to be sufficient for whole
genome transcriptional analysis. This data show that sev-
eral genes are differentially expressed in vivo, indicating
differences between the transcriptional program of 3D7
laboratory strain parasites growing in culture and natu-
rally occurring infections in the human host.
Whole genome expression has been used in studies of bac-
terial pathogenesis to identify genes that are specifically
transcribed under in vivo conditions [5-7]. For example,
genes involved in amino acid transport and metabolism
are upregulated in Pasteurella multocida in vivo as com-
pared to in vitro conditions [8]. Similarly, analysis of P. fal-
ciparum gene expression patterns, particularly the subset
of genes that are specifically expressed in the in vivo state
may identify unique parasite biology when it resides in
the host environment. Processes involving parasite
metabolism, immune evasion and transmission may be
altered in the highly specialized environment of the
human host as compared to in vitro conditions. In addi-
tion, approximately 12% of P. falciparum's predicted genes
have not been found to be expressed in any of the life
cycle stages previously studied [9]. Whole genomic analy-
sis of the parasite in vivo may reveal the unique expression
of such genes in vivo, providing additional targets for
intervention.
Methods
Parasite isolates
This study was conducted as part of an ongoing P. falci-
parum  chloroquine resistance study in Senegal [10].
Patients with mild P. falciparum malaria gave consent for
the study and were enrolled at an outpatient health clinic.
Patients underwent venipuncture using K3 EDTA coated
Vacutainers (Beckton Dickinson) and from this sample,
1.6–2.5 ml of whole blood was collected and passed
through a white cell depletion filter using a 20 ml syringe.
The filtered sample was centrifuged for 5 minutes at 3,200
rpm in a clinical centrifuge and placed in Tri-Reagent BD
(Molecular Research Center). The samples were vortexed
and stored at minus 70°C. Samples were thawed in a
room temperature bath one month later and isolation of
RNA was completed per Molecular Research Centers pro-
tocol. Three samples obtained in Senegal that had the
highest parasitemia and largest blood volume are pre-
sented. A 14 ml blood sample from a P. falciparum
infected traveler from Nigeria was similarly processed in
Boston.
Oligonucleotide array analysis
Labeling and hybridization of total RNA was performed as
described [2]. Expression levels were calculated using the
Match Only Integral Distribution Algorithm (MOID)
[11]. The presence or absence of gene expression was
determined using methods previously described [9]. The
design of the probes to human ESTs was based on Uni-
Gene version 116.
Real time PCR
To confirm array data, a subset of genes (PFB0120,
PFB0100, PFB0270 PFB0355, and PFB0065) that vary
from high to low level abundance by array were quanti-
fied using real time PCR from cDNA. PFB0120: forward
primer 5'-CAG CCC TCT TAG CTC TCA ACT TC-3', reverse
primer 5'-AGC AAC AGC AGA GGC TAT AGA ACT-3',
PFB0100: forward primer 5'-CAC CAA ATG GCT ATG CTT
ATG GA-3', reverse primer 5'-TTC CAG GAG CAC CAT
TAA ATC CT-3', PFB0270: forward primer 5'-ACA CTT
ACT GGT ATT TCG GAA TTT-3', reverse primer 5'-TAA
TTG TCC ATA TTC TTC AAT ATA T-3', PFB0355: forward
primer 5'-ATT GTA AGA AAT AGT TGG GGT-3', reverse
primer 5'-TAT ATC ATG CTC CTT CTT ATC A-3', PFB0065:
forward primer 5'-CGT TGG TAG TGC GTT CCT TAC AA-
3', reverse primer 5'-GTT CCT GCT ATA TCA GGA GCA
CCA-3'. Sequence analysis confirmed the identity of the
amplification products. 3D7 strain parasites were culti-
vated under standard conditions and synchronized with
5% sorbitol to obtain ring stage parasites for extraction of
total RNA [12,13]. cDNA was synthesized from total RNA
from the Nigerian in vivo sample and 3D7 ring stage total
RNA using Super Script 1st Strand synthesis system (Invit-
rogen). Duplicate reactions using real time PCR were per-
formed with 1 µl cDNA with gene specific primers in 50
µl reaction volume using fluorescent dye SYBR Green
(SYBR Green PCR Master Mix, Applied Biosystems). The
reactions were carried out on an ABI PRISM model 7700-
sequence detector and all PCR reactions amplified a single
product as determined by dissociation curve analysis (Dis-
sociation Curve Software, Applied Biosystems).
Statistical tests
Variation between samples was assessed using Kruskal-
Wallis method (non-parametric ANOVA) to test the null
hypothesis. To normalize samples, the mean gene expres-
sion level was calculated for all Plasmodium genes between
the 10th and 90th percentile with at least six probes. Anal-
ysis based on rank was a second method used; in each
experiment the probe intensity was ranked and this
resulted in equivalent quantile distribution for all probes
between two experiments. This method is more conserva-
tive and will define relative rank changes between experi-
ments and is independent of potential normalization
artifacts.
Human subjects
Patient blood samples were collected after informed con-
sent was obtained. The study was approved by the institu-
tional review boards at Harvard School of Public Health,Malaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
Page 3 of 8
(page number not for citation purposes)
Brigham and Women's Hospital and Cheikh Anta Diop
University.
Results
To evaluate the integrity of the RNA transcripts from the
in vivo isolated samples a denaturing RNA gel was carried
out (Figure 1). The ribosomal bands are sharp with mini-
mal RNA degradation. Despite buffy coat depletion there
are human ribosomal bands present in addition to P. fal-
ciparum ribosomal bands. Human ribosomal bands are
not seen on a denaturing RNA gel from in vitro cultivated
3D7 (data not shown). The most abundant transcript of
human origin in the in vivo was haemoglobin RNA (Table
1). Human transcripts are also detected in 3D7 in vitro
samples, but at a lower level of abundance.
The corresponding peripheral blood smears for the four in
vivo  samples contained only ring forms. Notably, only
ring stages are present in the peripheral blood of P. falci-
parum infected patients; later stages are sequestered in the
microvasculature. For this reason, the in vivo whole
genome transcription data was compared to the in vitro
chromosome 2 ring stage transcriptome. Three samples
with parasitemias that were less than 0.3% and total vol-
umes of up to 2.5 ml from Senegal were studied: this
resulted in the detection of fewer transcripts than the sam-
ple obtained from a Nigerian patient who had parasitemia
of 0.4% and underwent a larger blood draw. However,
50% of the top twenty five expressed transcripts in all four
samples were shared (data not shown). Further analysis
was performed on the Nigerian sample. Only one parasite
line was detected in this sample through DNA genotyping
of the K1, MAD20, RO33 alleles of msp1 and FC27 and
IC1 alleles of msp2 using primers and methods previously
reported [14]. After total RNA was isolated, aliquots of 8
µg of total RNA were labeled using a modified Eberwine
procedure [2]. To maximize parasite transcript detection,
15 µg to 120 µg of cRNA were hybridized to the array and
a quantitative expression level was calculated using the
MOID algorithm for the Plasmodium genes on the array
[2]. Correlation coefficients comparing P. falciparum chro-
mosome 2 expression levels utilizing 15 µg to 30 µg or 15
µg to 60 µg cRNA were 0.95 and 0.92, respectively. How-
ever, as cRNA concentration was increased to 120 µg, the
background to noise ratio increased significantly, result-
ing in a decreased correlation coefficient (R = 0.72) (Fig-
ure 2a,2b and 2c).
The most abundant transcripts detected from the Nigerian
in vivo sample are listed in Table 2. Genes in bold are
uniquely expressed in the in vivo sample compared to 3D7
ring stage previously reported using the Kruskal-Wallis
method [2]. Notably, a number of genes encoding surface
proteins such as rifins and SERA antigens appear overex-
pressed in vivo.
To confirm the accuracy of the results from the oligonucle-
otide array and to confirm the in vivo overexpression of a
SERA antigen (PFB0355), the relative expression of five
genes that had varying transcript abundance by array was
carried out using real time PCR of cDNA generated from
total RNA isolated from the Nigerian in vivo sample and a
3D7 in vitro ring stage sample. There is good correlation
between the array results and those obtained by real time
PCR (Figure 3). To compare abundance of PFB0355 cDNA
between the in vivo and in vitro samples, the data is nor-
malized to cDNA of PFB0120 to account for differences in
starting parasite cDNA, secondary to human cDNA. The in
vivo sample contained 0.15 ng cDNA of PFB0355c and
3D7 ring stage cDNA had 0.09 ng by real time PCR. When
PFB0355c is normalized to PFB0120c, it was found to be
ten fold overexpressed in vivo as compared to in vitro, con-
sistent with the array results.
Denaturing gel of total RNA isolated from P. falciparum  infected patient blood reveals both human and parasite ribos- omal RNA Figure 1
Denaturing gel of total RNA isolated from P. falciparum 
infected patient blood reveals both human and parasite ribos-
omal RNA. Total RNA was electrophoresed on a 1.3% for-
maldehyde agarose gel and stained with ethidium bromide. 
Marker (M) marks RNA size ladder. Three patient samples 
were run in lane 1–3. Closed arrows represent human ribos-
omal RNA 28s: 4700 bp, 18s:1900 bp; Open arrows mark P. 
falciparum ribosomal RNA 28s:4104 bp, 18s:1384 bp.Malaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
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Discussion
This data confirms that in vivo whole genomic expression
can be performed despite the potential technical chal-
lenges of scarce RNA contained in a small blood volume
sample and presence of abundant human RNA. Tri-Rea-
gent BD was used to stabilize RNA and the samples were
stored at -80°C before transport to the US. The denaturing
gel suggests that the RNA remains intact using this rea-
gent. Notably Kyes et al. reported that minus 80°C rather
than 4°C or minus 20°C is the optimal temperature to
store field sample RNA for detection of long transcripts
such as var [15]. Surprisingly, abundant human RNA was
detected in the denaturing gel despite buffy coat depletion
of the samples. In addition, the degree of hybridization to
human probes on the oligonucleotide array used here was
not seen in the previously studied in vitro sample [2].
Haemoglobin is found to be the most abundantly
expressed human transcript (Table 1) with considerably
higher levels noted in the in vivo samples as compared to
the 3D7 in vitro sample. Although human red cells are
used for culturing in the in vitro system, reticulocytes
which contribute to the haemoglobin detected are not
abundant in in vitro samples. This is most likely due to the
observation that reticulocyte levels display a 75% loss at
48 hours, when placed at 37°C, which is the condition of
in vitro culture [16]. In addition, other human RNA such
as ribosomal RNA is more abundant in the in vivo samples
and may be secondary to white cell contamination. Cross
hybridization of human RNA to parasite probes may
occur. However, Zhou et al have shown that human
genomic DNA does not highly cross hybridize to the par-
asite probes on this custom array [17]. The high specificity
of this array is due to the nature of the highly AT rich par-
asite genome as compared to the human genome and the
careful selection of parasite unique 25 mers probes
[2,18,19]. Due to this high specificity, it is likely that buffy
coat depletion is not necessary for analysis of in vivo para-
site transcripts when using these probes.
The amount of blood volume necessary for comprehen-
sive detection of transcription depends on level of
parasitemia and method of microarray analysis. This anal-
ysis utilized the Affymetrix system which requires very lit-
tle starting RNA as compared to other methods [20]. Due
to the presence of human RNA in the in vivo samples it was
not possible to determine how much parasite RNA is
required for whole genome analysis. The samples from
Senegal were of low parasitemia and small volumes,
Table 1: Human transcripts detected in P. falciparum infected patient blood samples and in vitro cultivated 3D7 samples Comparison of 
expression level of the most abundant human transcripts detected in in vivo blood and in 3D7 in vitro cultivated samples. Average 
expression level of in vivo isolated RNA derived from the average expression level of three samples from Senegal and one from Nigeria 
compared with the average expression level from three 3D7 ring stage in vitro isolated RNA samples. Transcripts are listed in order of 
highest abundance in vivo as detected by array. Expression levels are reported as expression units (EU), using the MOID algorithm.
Expression Units
Gene Description in vivo in vitro 3D7
Hs.155376_at haemoglobin, beta 757266 101307
Hs.36977_at haemoglobin, delta EST, similar to tctp human translationally controlled tumor 
protein H. sapiens
395849 12265
Hs.203820_at 241506 6932
Hs.21295_at EST, Weakly similar to KIAA0902 protein H. sapiens 190454 9321
Hs.247921_at haemoglobin, theta 1 188961 4528
Hs.87246_at Bcl-2 binding component 3 187575 5688
Hs.256047_at ESTs, similar to B24264 proline-rich protein MP3 -M. musculus 160290 5681
Hs.14587_at ESTs, similar to AF1 51 859_1 CGI-101 protein H. sapiens 155768 6389
Hs.117848_at haemoglobin, epsilon 1 150921 5903
Hs.168073_at DKFZP727M231 protein 147492 6615
Hs.24545_at hypothetical protein FLJ11137 146324 6292
Hs.6318_at peroxisomal short-chain alcohol dehydrogenase 145846 5136
Hs.155833_at ESTs, similar to spliceosomal protein SAP 155 H. sapiens Homo sapiens mRNA; 
cDNA DKFZp434H0820 (from clone DKFZp434H0820); partial cds
140563 5508
Hs.109857_at 138856 7397
Hs.248677_at ESTs, similar to A48018 mucin 7 precursor, salivary – H. sapiens 136390 5253
Hs.4205_at hypothetical protein FLJ20124 ATPase, H+ transporting, lysosomal (vacuolar proton 
pump), member D
132244 4050
Hs.106876_at 127582 3930
Hs.172914_at retinol dehydrogenase 5 (11-cisand 9-cis) 125310 4560
Hs.23898 at paraneoplastic antigen 124648 5631Malaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
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Scatter plot of expression level variance between samples to define the highest signal to background ratio of calculated expres- sion units for P. falciparum probes Figure 2
Scatter plot of expression level variance between samples to define the highest signal to background ratio of calculated expres-
sion units for P. falciparum probes. Increasing concentrations of cRNA from the Nigerian sample were hybridized to the array 
and expression levels (Expression Units) for each transcript were derived using the MOID algorithm. 15 µg cRNA data is pre-
sented on the Y axis (a) 15 µg v. 30 µg of starting cRNA. (b) 15 µg v. 60 µg starting cRNA. (c) and 15 µg v. 120 µg starting 
cRNA. (R = correlation coefficient).Malaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
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whereas the 14 ml blood sample with 0.4% parasitemia
was sufficient to detect a greater number of chromosome
2 transcripts. Four to five mls of packed blood in a patient
with a greater than 2% parasitemia should provide suffi-
cient material for whole genome analysis using these
methods. The data demonstrates the reproducibility of the
method by independent hybridizations and that maximal
senstivity can be achieved with up to 60 µg of cRNA, using
this array.
PFB0120w is the most abundant in vivo transcript in all
samples encoded on chromosome 2. This gene is a mem-
ber of a recently described gene family, etramps, expressed
at early ring stage encoding a protein thought to be
involved in erythrocyte remodeling; this was also the most
highly expressed transcript in in vitro ring stage cultures
[2,21,22]. The in vivo expressed genes from the Nigerian
sample was compared to that of the in vitro 3D7 ring stage
chromosome 2 transcriptome [2]. As expected, there was
a good correlation between the in vivo ring stage transcrip-
tome and the 3D7 ring stage transcriptome. Most of the
genes that are expressed in vivo are also expressed in vitro
particularly those involved in cellular function and genes
encoding hypothetical proteins (Table 2) [2]. A number of
differentially expressed genes involved in transmission
and antigenic variation were identified. There is high tran-
scription level of transmission blocking target antigen
(PFB0405w) in the in vivo samples. Previously this gene
has been demonstrated to be expressed and transcribed
only in the sexual transmission stage [3,9]. Since no trans-
missible forms were identified by microscopy this sug-
gests that the in vivo samples may have more parasites that
Table 2: P. falciparum genes expressed in vivo encoded by chromosome 2. In vivo transcripts from the Nigerian sample were defined as 
present as compared to uninfected blood control hybridization. Asterisk (*) denotes transcripts that were also detected in a Senegal 
derived blood sample. Genes in bold are uniquely expressed in vivo and were not found to be expressed in the previously reported 3D7 
ring stage transcriptome. Gene locus is from PlasmoDB 4.1 http://plasmodb.org/.
gene locus description gene locus description
membrane proteins cellular function
PFB0120w* etramps 2 PFB0175c* prt of the MAK16 family
PFB0405w* transmission blocking target antigen PFB0205c prt with 5'-3' exonucl. domain
PFB0015c rifin PFB0210c monosaccharide transporter
PFB0025c rifin PFB0265c* RAD2 endonucl.
PFB0035c rifin PFB0295w* adenylosuccinate lyase (OO)
PFB1010w* rifin PFB0380c phosphatase (acid phosphatase family)
PFB1020w* rifin PFB0390w* ribosome releasing factor (OO, TP)
PFB1035w* rifin PFB0410c* phospholipase A2-like a/b fold 
hydrolase
PFB1050w* rifin PFB0445c elF-4A-like DEAD family RNA helicase
PFB0330c SERA antigen/papain-like protease PFB0510w GAF domain prt
PFB0340c SERA antigen/papain-like protease PFB0525w asparaginyl-tRNA synthetase (OO, TP)
PFB0345c* SERA antigen/papain-like protease PFB0585w Leu/Phe-tRNA prt transferase
PFB0355c* SERA antigen/papain-like protease PFB0595w* prt with DnaJ domain, DNJ1/SIS1 family
PFB0360c SERA antigen/papain-like protease PFB0760w Mtn3/RAG1IP-like prt
PFB0095c membrane protein, PfEMP3 PFB0795w ATP synthase alpha chain
PFB0975c PfEMP1 fragment PFB0815w* calcium-dept. prt kinase
PFB1045w Pf EMP1 fragment PFB0875c chromatin-binding prt (SKI/SNW family)
PFB1055c PfEMP1 (var gene) hypothetical proteins
PFB0085c* prt with DnaJ domain (RESA-like) PFB0135c hypothetical protein
PFB0100c* knob-associated His-rich prt PFB0490c* hypothetical protein
PFB0300c merozoite surface antigen MSP-2 PFB0575c hypothetical protein
PFB0475c predicted multiple-TM membrane prt PFB0580w hypothetical protein
PFB0770c* predicted multiple-TM membrane prt PFB0630c hypothetical protein
PFB0125c predicted membrane associated prt PFB0705w hypothetical protein
PFB0735c predicted integral membrane protein PFB0745w hypothetical protein
PFB0275w* membrane transporter PFB0870w hypothetical protein
PFB0465c membrane transporter other
PFB0675w predicted secreted protein
PFB0990c predicted secreted proteinMalaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
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are undergoing or are committed to sexual development
than is detectable by microscopy. Several genes encoding
membrane proteins, including SERA and rifin genes, were
also found to be differentially expressed. These genes are
members of multigene family that encode surface proteins
which are thought to be involved in immune evasion
[23,24]. The observed increase in transcription for these
genes in vivo could be due either to genetic or transcrip-
tional modulation of the parasite's defense repertoire or
geographic variation. Differences between the in vivo and
in vitro expression of SERA antigens may be due to differ-
ences in the in vivo stage of development as this gene fam-
ily is transcribed at later stages in the in vitro life cycle
[2,4,25]. There was overall higher hybridization intensity
of the in vitro samples due to higher parasite counts and a
subset of genes were found to be overexpressed in vitro
after normalization. This analysis focussed on genes over-
expressed in vivo as these results would not be influenced
by normalization algorithms. Overall, this data demon-
strates that P. falciparum transcripts can be detected from
in vivo samples, and that there are potentially important
differences between trancription of in vivo samples and
that of the 3D7 in vitro trancription profile.
In summary, this study provides evidence that whole
genome gene expression in P. falciparum can be studied in
vivo from a small blood sample of an infected patient. The
in vivo sample however contains human RNA, whose
quantity may vary from sample to sample and therefore
differenes in parasite transcript level between samples
must be reported relative to a reference transcript. Despite
the abundance of human RNA the genomes are suffi-
ciently different with resultant probes specificity. Predict-
ably, there was a high correlation of in vivo expression
with the in vitro ring stage 3D7 transcriptome [2]. Impor-
tantly these data also suggest differences between in vivo
and in vitro expression levels in genes typically found in
transmissable forms and encoding variant surface
proteins. Evaluation of trancription of genes specific for
gametocyte development in specific patient populations
may uncover the in vivo conditions that favor develop-
ment of transmissable forms. Similarily, a whole genome
analysis can comprehensively characterize expression of
multigene families that encode variant surface proteins
under in vivo conditions. Further exploration of the in vivo
biology of P. falciparum using specific probes to all anno-
tated genes will be undertaken to confirm and explore
other important biological differences. This new approach
will further the understanding of the host-pathogen inter-
action and may result in the development of new strate-
gies to combat this disease.
References
1. Ben Mamoun C, Gluzman IY, Hott C, MacMillan SK, Amarakone AS,
Anderson DL, Carlton JM, Dame JB, Chakrabarti D, Martin Brown-
stein B, Goldberg D: Co-ordinated programme of gene expres-
sion during asexual intraerythrocytic development of the
human malaria parasite Plasmodium falciparum revealed by
microarray analysis. Mol Microbiol 2001, 39:26-36.
2. Le Roch KG, Zhou Y, Batalov S, Winzeler EA: Monitoring the
chromosome 2 intraerythrocytic transcriptome of Plasmo-
dium falciparum using oligonucleotide arrays. Am J Trop Med
Hyg 2002, 67:233-243.
3. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes
JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D,
Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ: A
proteomic view of the Plasmodium falciparum life cycle. Nature
2002, 419:520-526.
4. Bozdech Z, Zhu J, Joachimiak MP, Cohen FE, Pulliam B, DeRisi JL:
Expression profiling of the schizont and trophozoite stages
of  Plasmodium falciparum with a long-oligonucleotide
microarray. Genome Biol 2003, 4:R9.
5. Heithoff DM, Conner CP, Hentschel U, Govantes F, Hanna PC,
Mahan MJ: Coordinate intracellular expression of Salmonella
genes induced during infection. J Bacteriol 1999, 181:799-807.
6. Chiang SL, Mekalanos JJ, Holden DW: In vivo genetic analysis of
bacterial virulence. Annu Rev Microbiol 1999, 53:129-154.
7. Basso H, Rharbaoui F, Staendner LH, Medina E, Garcia-Del Portillo F,
Guzman CA: Characterization of a novel intracellularly acti-
vated gene from Salmonella enterica serovar typhi. Infect Immun
2002, 70:5404-5411.
8. Boyce JD, Wilkie I, Harper M, Paustian ML, Kapur V, Adler B:
Genomic scale analysis of Pasteurella multocida gene expres-
sion during growth within the natural chicken host.  Infect
Immun 2002, 70:6871-6879.
9. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De
La Vega P, Holder AA, Batalov S, Carucci DJ, Winzeler EA: Discov-
ery of gene function by expression profiling of the malaria
parasite life cycle. Science 2003, 301:1503-1508.
10. Thomas SM, Ndir O, Dieng T, Mboup S, Wypij D, Maguire JH, Wirth
DF: In vitro chloroquine susceptibility and PCR analysis of
pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum
isolates from Senegal. Am J Trop Med Hyg 2002, 66:474-480.
11. Zhou Y, Abagyan R: Match-Only Integral Distribution (MOID)
Algorithm for high-density oligonucleotide array analysis.
BMC Bioinformatics 2002, 3:3.
Correlation of expression levels derived from the oligonucle- otide array with ng cDNA determined by real time PCR Figure 3
Correlation of expression levels derived from the oligonucle-
otide array with ng cDNA determined by real time PCR. Log 
ng of cDNA from the Nigerian sample and the in vitro 3D7 
ring stage sample was determined for five genes that vary 
from high to low level abundance by array: PFB0120, 
PFB0100, PFB0270, PFB0355, and PFB0065. cDNA concen-
tration was determined with real time PCR using a standard 
curve based on 3D7 genomic DNA. These results were cor-
related to the expression units (EU) found by the array. (R2 = 
correlation coefficient)Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2004, 3:30 http://www.malariajournal.com/content/3/1/30
Page 8 of 8
(page number not for citation purposes)
12. Trager W, Jensen JB: Human malaria parasites in continuous
culture. Science 1976, 193:673-675.
13. Lambros C, Vanderberg JP: Synchronization of Plasmodium falci-
parum  erythrocytic stages in culture.  J Parasitol 1979,
65:418-420.
14. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Vir-
iyakosol S: Biased distribution of msp1 and msp2 allelic vari-
ants in Plasmodium falciparum populations in Thailand. Trans
R Soc Trop Med Hyg 1999, 93:369-374.
15. Kyes S, Pinches R, Newbold C: A simple RNA analysis method
shows var and rif multigene family expression patterns in
Plasmodium falciparum. Mol Biochem Parasitol 2000, 105:311-315.
16. Hansson GK, Andersson M, Jarl H, Stemme S: Flow cytometric
analysis of reticulocytes using an RNA-binding
fluorochrome. Scand J Clin Lab Invest 1992, 52:35-41.
17. Zhou Y, Abagyan R: Algorithms for high-density oligonucle-
otide array. Curr Opin Drug Discov Devel 2003, 6:339-345.
18. Gardner MJ, Tettelin H, Carucci DJ, Cummings LM, Aravind L, Koonin
EV, Shallom S, Mason T, Yu K, Fujii C, Pederson J, Shen K, Jing J, Aston
C, Lai Z, Schwartz DC, Pertea M, Salzberg S, Zhou L, Sutton GG,
Clayton R, White O, Smith HO, Fraser CM, Hoffman SL: Chromo-
some 2 sequence of the human malaria parasite Plasmodium
falciparum. Science 1998, 282:1126-1132.
19. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J,
Devon K, Dewar K, Doyle M, FitzHugh W, International Human
Genome Sequencing Consortium: Initial sequencing and analysis
of the human genome. Nature 2001, 409:860-921.
20. Tefferi A, Bolander ME, Ansell SM, Wieben ED, Spelsberg TC:
Primer on medical genomics. Part III: Microarray experi-
ments and data analysis. Mayo Clin Proc 2002, 77:927-940.
21. Spielmann T, Fergusen DJ, Beck HP: Etramps, a new Plasmodium
falciparum gene family coding for developmentally regulated
and highly charged membrane proteins located at the para-
site-host cell interface. Mol Biol Cell 2003, 14(4):1529-1544.
22. Blisnick T, Morales Betoulle ME, Barale JC, Uzureau P, Berry L,
Desroses S, Fujioka H, Mattei D, Braun Breton C: Pfsbp1, a Mau-
rer's cleft Plasmodium falciparum protein, is associated with
the erythrocyte skeleton.  Mol Biochem Parasitol 2000,
111(1):107-121.
23. Miller SK, Good RT, Drew DR, Delorenzi M, Sanders PR, Hodder
AN, Speed TP, Cowman AF, de Koning-Ward TF, Crabb BS: A sub-
set of Plasmodium falciparum SERA genes are expressed and
appear to play an important role in the erythrocytic cycle. J
Biol Chem 2002, 277:47524-47532.
24. Abdel-Latif MS, Khattab A, Lindenthal C, Kremsner PG, Klinkert MQ:
Recognition of variant Rifin antigens by human antibodies
induced during natural Plasmodium falciparum infections.
Infect Immun 2002, 70:7013-7021.
25. Aoki S, Li J, Itagaki S, Okech BA, Egwang TG, Matsuoka H, Palacpac
NM, Mitamura T, Horii T: Serine repeat antigen (SERA5) is pre-
dominantly expressed among the SERA multigene family of
Plasmodium falciparum, and the acquired antibody titers cor-
relate with serum inhibition of the parasite growth. J Biol Chem
2002, 277:47533-47540.